Excelsior Biopharma Inc. (TPEX:6496)
Taiwan · Delayed Price · Currency is TWD 28.85
+0.05 (0.17%)
Jan 22, 2026, 1:30 PM CST
Excelsior Biopharma Market Cap
Excelsior Biopharma has a market cap or net worth of 1.35 billion as of January 22, 2026. Its market cap has decreased by -4.27% in one year.
Market Cap
1.35B
Enterprise Value
1.64B
Revenue
859.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.85
Market Cap Chart
Since December 23, 2014, Excelsior Biopharma's market cap has decreased from 2.86B to 1.35B, a decrease of -53.00%. That is a compound annual growth rate of -6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.35B | -1.54% |
| Dec 31, 2025 | 1.37B | -2.78% |
| Dec 31, 2024 | 1.41B | 3.69% |
| Dec 29, 2023 | 1.36B | 4.50% |
| Dec 30, 2022 | 1.30B | -4.79% |
| Dec 30, 2021 | 1.36B | -1.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 2.42B |
| TSH Biopharm Corporation | 2.14B |
| GeneFerm Biotechnology | 1.90B |
| InnoPharmax | 1.77B |
| Winston Medical Supply | 1.46B |
| DV Biomed | 1.43B |
| Tien Liang BioTech | 1.39B |
| Mediera | 1.14B |